Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 83 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 21 X posts from 8 X users, with an upper bound of 27,912 followers.

Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma. https://t.co/owLXQUIU9P

27 Jun 2018

Reply Repost Favourite

#JITC Research Article: Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV #melanoma https://t.co/yylCZoXM7c https://t.co/vU0GUGhjR2

18 Dec 2017

Reply Repost Favourite

RT @sitcancer: #JITC Research Article: Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with…

17 Dec 2017

Reply Repost Favourite

RT @sitcancer: #JITC Research Article: Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with…

16 Dec 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.